We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week
Published in Brain Cancer

Journal Scan / Research · November 05, 2020

TERT Promoter Mutation Analysis for Blood-Based Diagnosis and Monitoring of Gliomas

Clinical Cancer Research

 

Additional Info

Clinical Cancer Research
TERT Promoter Mutation Analysis for Blood-Based Diagnosis and Monitoring of Gliomas
Clin. Cancer Res 2020 Oct 13;[EPub Ahead of Print], K Muralidharan, A Yekula, JL Small, ZS Rosh, KM Kang, L Wang, S Lau, H Zheng, H Lee, C Bettegowda, MR Chicoine, S Kalkanis, GM Shankar, BV Nahed, WT Curry, PS Jones, DP Cahill, L Balaj, BS Carter

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading